Literature DB >> 13314439

Contributions of the ascites hepatoma to the concept of malignancy of cancer.

T YOSHIDA.   

Abstract

Entities:  

Keywords:  HEPATOMA/experimental; NEOPLASMS/pathology

Mesh：

Year:  1956        PMID： 13314439     DOI： 10.1111/j.1749-6632.1956.tb50897.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

Review 1.  The difficulty of targeting cancer stem cell niches.

Authors:  Mark A LaBarge
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  [Studies on ascites hepatoma; also a contribution to the cellular anatomy of malignant tumors during growth, and the individuality of single tumors].

Authors:  T YOSHIDA
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1957

3.  [Effect of nitrogen mustard gas and colchicine on serum proteins].

Authors:  C SCHOLTISSEK
Journal:  Z Krebsforsch       Date:  1956

4.  [Some recent studies on the production and growth characteristics of ascites tumors; a review].

Authors:  G KLEIN
Journal:  Z Krebsforsch       Date:  1956

5.  Isolation and characterization of the plasma membrane from Yoshida hepatoma cells.

Authors:  A Réthy; A Trevisani; R Manservigi; V Tomasi
Journal:  J Membr Biol       Date:  1975       Impact factor: 1.843

6.  [Quantitative study of the Yoshida AH 130 ascites hepatoma].

Authors:  G Bombara; D Morabito
Journal:  Z Krebsforsch       Date:  1966

7.  Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines.

Authors:  T Kawaguchi; S Igarashi; H Wakabayashi; S Yokoya; K Fukui
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

8.  Disposition kinetics of taxanes in peritoneal dissemination.

Authors:  Ken'ichi Miyamoto; Tsutomu Shimada; Kazuki Sawamoto; Yoshimichi Sai; Yutaka Yonemura
Journal:  Gastroenterol Res Pract       Date:  2012-05-16       Impact factor: 2.260

9.  Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins.

Authors:  S Wakusawa; S Nakamura; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1997-01

10.  In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).

Authors:  T Minamino; M Tamai; Y Itoh; Y Tatsumi; M Nomura; K Yokogawa; H Suzuki; Y Sugiyama; T Ohshima; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1999-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.